Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check5 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 has been removed.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.4.2 was added and the government funding status notice about potential data unavailability and response delays was removed.SummaryDifference0.4%

- Check47 days agoChange DetectedA site-wide notice about the lapse in government funding was added, with links to cc.nih.gov and opm.gov, and the page version updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check54 days agoChange DetectedThe page now includes a glossary toggle and minor label/case updates, plus a new revision note v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page's revision history was updated to add Revision v3.3.4 and remove Revision v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.